| F-18 labelled PSMA-1007: biodistribution, radiation dosimetry and histopathological validation of tumor lesions in prostate cancer patients FL Giesel, B Hadaschik, J Cardinale, J Radtke, M Vinsensia, W Lehnert, ... European journal of nuclear medicine and molecular imaging 44, 678-688, 2017 | 579 | 2017 |
| Multiparametric magnetic resonance imaging (MRI) and MRI–transrectal ultrasound fusion biopsy for index tumor detection: correlation with radical prostatectomy specimen JP Radtke, C Schwab, MB Wolf, MT Freitag, CD Alt, C Kesch, ... European urology 70 (5), 846-853, 2016 | 309 | 2016 |
| The value of PSA density in combination with PI-RADS™ for the accuracy of prostate cancer prediction FA Distler, JP Radtke, D Bonekamp, C Kesch, HP Schlemmer, ... The Journal of urology 198 (3), 575-582, 2017 | 244 | 2017 |
| Combined clinical parameters and multiparametric magnetic resonance imaging for advanced risk modeling of prostate cancer—patient-tailored risk stratification can reduce … JP Radtke, M Wiesenfarth, C Kesch, MT Freitag, CD Alt, K Celik, F Distler, ... European urology 72 (6), 888-896, 2017 | 184 | 2017 |
| Multicentre evaluation of magnetic resonance imaging supported transperineal prostate biopsy in biopsy‐naïve men with suspicion of prostate cancer NL Hansen, T Barrett, C Kesch, L Pepdjonovic, D Bonekamp, R O'Sullivan, ... BJU international 122 (1), 40-49, 2018 | 159 | 2018 |
| 68Ga or 18F for prostate cancer imaging? C Kesch, C Kratochwil, W Mier, K Kopka, FL Giesel Journal of Nuclear Medicine 58 (5), 687-688, 2017 | 141 | 2017 |
| Multicentre evaluation of targeted and systematic biopsies using magnetic resonance and ultrasound image‐fusion guided transperineal prostate biopsy in patients with a previous … NL Hansen, C Kesch, T Barrett, B Koo, JP Radtke, D Bonekamp, ... BJU international 120 (5), 631-638, 2017 | 139 | 2017 |
| Intraindividual comparison of 18F-PSMA-1007 PET/CT, multiparametric MRI, and radical prostatectomy specimens in patients with primary prostate cancer: a retrospective, proof-of … C Kesch, M Vinsensia, JP Radtke, HP Schlemmer, M Heller, E Ellert, ... Journal of Nuclear Medicine 58 (11), 1805-1810, 2017 | 117 | 2017 |
| 68Ga-PSMA-11 PET/CT in newly diagnosed carcinoma of the prostate: correlation of intraprostatic PSMA uptake with several clinical parameters SA Koerber, MT Utzinger, C Kratochwil, C Kesch, MF Haefner, ... Journal of Nuclear Medicine 58 (12), 1943-1948, 2017 | 106 | 2017 |
| Prostate segmentation in MRI using a convolutional neural network architecture and training strategy based on statistical shape models D Karimi, G Samei, C Kesch, G Nir, SE Salcudean International journal of computer assisted radiology and surgery 13, 1211-1219, 2018 | 96 | 2018 |
| Improved detection of anterior fibromuscular stroma and transition zone prostate cancer using biparametric and multiparametric MRI with MRI-targeted biopsy and MRI-US fusion … JP Radtke, S Boxler, TH Kuru, MB Wolf, CD Alt, IV Popeneciu, ... Prostate cancer and prostatic diseases 18 (3), 288-296, 2015 | 85 | 2015 |
| Biochemical recurrence of prostate cancer: initial results with [18F] PSMA-1007 PET/CT FL Giesel, L Will, C Kesch, M Freitag, C Kremer, J Merkle, OC Neels, ... Journal of Nuclear Medicine 59 (4), 632-635, 2018 | 66 | 2018 |
| Prospective comparison of transperineal magnetic resonance imaging/ultrasonography fusion biopsy and transrectal systematic biopsy in biopsy‐naïve patients A Borkowetz, B Hadaschik, I Platzek, M Toma, G Torsev, T Renner, ... BJU international 121 (1), 53-60, 2018 | 62 | 2018 |
| 18F-PSMA-1007 PET/CT detects micrometastases in a patient with biochemically recurrent prostate cancer FL Giesel, C Kesch, M Yun, J Cardinale, U Haberkorn, K Kopka, ... Clinical Genitourinary Cancer 15 (3), e497-e499, 2017 | 61 | 2017 |
| Detection of significant prostate cancer using target saturation in transperineal magnetic resonance imaging/transrectal ultrasonography–fusion biopsy S Tschirdewahn, M Wiesenfarth, D Bonekamp, L Püllen, H Reis, A Panic, ... European Urology Focus 7 (6), 1300-1307, 2021 | 60 | 2021 |
| High fibroblast-activation-protein expression in castration-resistant prostate cancer supports the use of FAPI-molecular theranostics C Kesch, L Yirga, K Dendl, A Handke, C Darr, U Krafft, JP Radtke, ... European journal of nuclear medicine and molecular imaging 49, 385-389, 2021 | 51 | 2021 |
| FAP imaging in rare cancer entities—first clinical experience in a broad spectrum of malignancies K Dendl, R Finck, FL Giesel, C Kratochwil, T Lindner, W Mier, J Cardinale, ... European journal of nuclear medicine and molecular imaging 49 (2), 721-731, 2022 | 42 | 2022 |
| Standardized magnetic resonance imaging reporting using the prostate cancer radiological estimation of change in sequential evaluation criteria and magnetic resonance imaging … S Dieffenbacher, J Nyarangi-Dix, F Giganti, D Bonekamp, C Kesch, ... European Urology Focus 7 (1), 102-110, 2021 | 41 | 2021 |
| A partial augmented reality system with live ultrasound and registered preoperative MRI for guiding robot-assisted radical prostatectomy G Samei, K Tsang, C Kesch, J Lobo, S Hor, O Mohareri, S Chang, ... Medical image analysis 60, 101588, 2020 | 39 | 2020 |
| Simultaneous whole-body 18F–PSMA-1007-PET/MRI with integrated high-resolution multiparametric imaging of the prostatic fossa for comprehensive oncological … MT Freitag, C Kesch, J Cardinale, P Flechsig, R Floca, M Eiber, ... European Journal of Nuclear Medicine and Molecular Imaging 45, 340-347, 2018 | 36 | 2018 |
